Celgene Corp (CELG)
$90.36 0.55 (0.60%)
12:06 EDT CELG Stock Quote Delayed 15 Minutes
Previous Close $90.91
Market Cap 63.87B
PE Ratio 25.17
Volume (Avg. Vol.) 1.12M
Day's Range 90.27 - 90.99
52-Week Range 58.59 - 98.97
Dividend & Yield N/A (N/A)
CELG Stock Predictions, Articles, and Celgene Corp News
- From InvestorPlace
- From the Web
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
Trump says that Facebook and Alphabet should be sued, while Micron surged on earnings. Semiconductors got a big boost in the Nasdaq today as well.
The stock market is off to its best year since 1997, and these tech stocks are leading that record rally. Here's what you should know.
AbbVie is buying Allergan, FedEx and Blackberry are reporting earnings and Microsoft is on the move. Here are our top stock trades.
The stock charts of EA, AAP and MGM have run through the technical trading wringer in front of today's action.
Bristol-Myers Squibb, Celgene, Caesars Entertainment, Match Group and New Relic are our top stock trades for Tuesday.
Bristol-Meyers Squibb news for Monday has BMY stock taking a beating after announcing a delay to its merger deal with Celgene.
Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.
The stock charts of CELG, AAL and MYL stock are going to start the new trading week out in a clear technical condition.
Bristol-Myers Squibb earnings for the first quarter of 2019 have BMY stock up Thursday on an earnings per share and revenue beat.
Celgene and Bristol-Myers got the green light from shareholders to move forward on the deal. More upside awaits for CELG stock.
Restoration Hardware, Bristol-Myers, Celgene, Lyft's IPO and Wells Fargo are our top stock trades to watch for Monday.
Celgene news concerning the company's ongoing deal with Bristol-Myers Squibb (BMS) has CELG stock on the rise for Friday.
Options trading was buzzing in Southwest Airlines, Celgene, and Square on Thursday. Here are the metrics that matter moving forward.
Bristol-Myers deal for Celgene is in doubt, while Box, Square, JD.com and Fitbit are moving on earnings. Here's are top stock trades for Friday.
Celgene stock was on its way down Thursday following news that major investors are against a deal with Bristol-Meyers (BMY).
Options trading was buzzing in Bristol-Myers, Activision Blizzard and Intel hursday. Here are the metrics that matter moving forward.
Gilead stock has been stagnating, but there are other choices for investors. How about considering Celgene over GILD stock?
From Market News Video
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Celgene Corp (CELG), where a total volume of 19,314 contracts has been traded thus far today, a contract volume which is representative of approximately 1.9 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 42.6% of CELG's average daily trading volume over the past month, of 4.5 million shares..
From Seeking Alpha
From Talk Markets
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!